FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine and pharmaceutics and represents an agent for treating erectile dysfunction, containing as active substance 9-phenyl-simm-octahydroselenoxantene in amount of 5–20 wt. % and excipients, wherein agent can be made in form of capsules or tablets.
EFFECT: technical result consists in treating erectile dysfunction by means of the invention, which does not exhibit side effects in patients with accompanying somatic pathologies.
3 cl, 6 dwg, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING THE DEVELOPMENT OF ERECTILE DYSFUNCTION IN PATIENTS AFTER URETHRAL TRAUMA | 2006 |
|
RU2308271C1 |
| USE OF PHARMACEUTICAL COMPOSITION OF β-CYCLODEXTRIN WITH 9-PHENYL-2,3,4,5,6,7,8,9-OCTAHYDRO-1H-SELENOXANTHENE FOR INCREASING/RESTORING LIBIDO | 2019 |
|
RU2782133C2 |
| ALPHA-CRYSTALLINE FORM OF SUBSTITUTED SELENOXANTHENES AND METHOD OF PRODUCING SAID FORM | 2008 |
|
RU2374238C1 |
| MEDICATION FOR PREVENTION AND TREATMENT OF ANDROLOGICAL DISEASES AND METHOD OF OBTAINING THEREOF | 2013 |
|
RU2519226C1 |
| USING NEUREGULIN FOR TREATING PERIPHERAL NERVES INJURY | 2018 |
|
RU2715908C2 |
| USING NEUREGULIN FOR TREATING PERIPHERAL NERVE INJURY | 2010 |
|
RU2575570C2 |
| APPLICATION OF NEUREGULIN FOR TREATMENT OF PERIPHERAL NERVE DAMAGE | 2010 |
|
RU2657770C1 |
| METHOD OF SURGICAL TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS AFTER RADICAL PROSTATECTOMY | 2020 |
|
RU2744052C1 |
| METHOD FOR ERECTILE DYSFUNCTION TREATMENT | 2016 |
|
RU2622757C1 |
| METHOD FOR DIAGNOSTICS OF VASCULAR AND GENETIC ERECTILE DYSFUNCTION | 2006 |
|
RU2336820C2 |
